Strong Buy Rating for Royalty Pharma: Robust Revenue Growth and Promising Pipeline
In a report released yesterday, Charlie CY Yang from Bank of America Securities reiterated a Buy rating on Royalty Pharma (RPRX – Research ...
Royalty Pharma price target raised to $39 from $38 at BofA
BofA analyst Charlie Yang raised the firm’s price target on Royalty Pharma (RPRX) to $39 from $38 and keeps a Buy rating on the shares. The ...
Global News1d
Global National homepage
The Conservative leader said he will work to bring foreign investment and industry back to Canada with policies similar to Trump's vows to slash taxes and regulations.
Australian Broadcasting Corporation1d
New South Wales
Veteran broadcaster Alan Jones has been charged with historical indecent assault and sexual touching offences spanning two decades.